VENUS REMEDIES Share Price

NSE: VENUSREM
|
Pharmaceuticals

₹ 1,575.90

-₹9.60 (-0.61%)
1D
Last updated 14 Oct, 2026, 15:29 IST

VENUS REMEDIES Share Price Today

As of 15 Oct 2026, VENUS REMEDIES share price is ₹1,575.90. The stock opened at ₹1,586.40, compared to its previous close of ₹1,585.50. During today's trading session, VENUS REMEDIES share price moved in the range of ₹1,550.00 to ₹1,605.00, with an average price of ₹1,577.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹432.10 and a high of ₹2,044.30. On the performance front, VENUS REMEDIES share price has increased by 51.35% over the last six months and is up 248.22% on a year-on-year basis.

₹1,550.00
0.61% down today
₹1,605.00
1D LOW
1D HIGH

VENUS REMEDIES Returns Calculator

Volume
14,939
Average traded price
₹1,575.02
Last traded time
03:29:45 14 Oct
Last traded quantity
1
Circuit
L
H
₹1,506.30
₹1,664.70
52-week
L
H
₹432.10
₹2,044.30
Mkt Cap Cr
2,172.94
P/E
18.22
P/B
3.19
ROA
13.61%
ROE
15.49%
ROCE
19.85%
Quick Ratio
1.64
EV/EBITDA
12.08
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Venus Remedies outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Venus Remedies appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Venus Remedies earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,19,619.6935.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,10,823.44101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,07,446.7932.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma96,243.6447.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About VENUS REMEDIES

ISIN
INE411B01019
Sector Market Cap
₹ 2,172.94 Cr

Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.

VENUS REMEDIES Financial Highlights

  • Revenue: VENUS REMEDIES reported revenue of ₹782.18 crore in FY26 vs ₹668.84 crore in FY25. It showed an increase of 16.95% on a yearly basis.
  • Operating Profit: VENUS REMEDIES reported an operating profit of ₹134.16 crore in FY26 vs ₹71.82 crore in FY25. It showed an increase of 86.80% on a year-on-year basis.
  • Net Profit: VENUS REMEDIES reported a net profit of ₹102.79 crore in FY26 vs ₹45.32 crore in FY25. It showed an increase of 126.81% on a yearly basis.

VENUS REMEDIES Quarterly Result Highlights

  • VENUS REMEDIES reported revenue of ₹181.48 crore in Jun 2026, compared with ₹264.35 crore in Mar 2026, representing a decrease of 31.35% on a quarter-on-quarter (QoQ) basis.
  • VENUS REMEDIES reported an operating profit of ₹30.04 crore in Jun 2026, compared with ₹61.61 crore in Mar 2026, representing a decrease of 51.24% on a quarter-on-quarter (QoQ) basis.
  • VENUS REMEDIES reported a profit of ₹22.97 crore in Jun 2026, compared with ₹47.50 crore in Mar 2026, reflecting a decrease of 51.64% on a QoQ basis.
  • The earnings per share (EPS) of VENUS REMEDIES stood at ₹33.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
41.76%
FII
3.14%
Other DII
0.74%
Retail and other
54.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.26%
Mar 20262.80%
Jun 20262.92%
Sep 20263.14%
1 day
-0.71%
1 week
-11.03%
1 month
-2.60%
1 year
+248.22%
3 years
+592.15%
5 years
+281.56%
Day
Open / Close
Change %
14 Oct 26
₹1,586.40 / ₹1,575.90
-0.61%
13 Oct 26
₹1,605.00 / ₹1,585.50
-2.15%
12 Oct 26
₹1,610.00 / ₹1,620.40
+0.64%
09 Oct 26
₹1,636.60 / ₹1,610.10
-4.22%
Show more

VENUS REMEDIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹647.89₹601.45₹555.51₹600.18
Other Income₹20.96₹11.58₹10.32₹8.31
Total Revenue₹668.84₹613.03₹565.83₹608.49
Total Expenses₹606.93₹568.39₹527.90₹572.08
Profit Before Tax₹71.83₹44.64₹37.93₹36.41
Tax₹26.51₹16.15₹11.36-₹4.32
Profit After Tax₹45.31₹28.49₹26.57₹40.72
EPS - Basic₹33.90₹21.31₹19.88₹30.86
EPS - Diluted₹33.90₹21.31₹19.88₹30.86

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹134.15₹61.87₹44.64₹37.93
Income before WC changes₹152.52₹78.95₹64.88₹61.26
Change in Assets-₹22.08₹8.79-₹45.64-₹86.18
Change in Liabilities₹59.59₹13.62₹33.53₹61.55
Change in WC₹37.52₹22.42-₹12.11-₹24.63
Cash flow from Operations₹155.77₹86.44₹37.29₹36.63
Cash flow from Investing-₹181.57-₹76.25-₹7.21-₹50.83
Cash flow from Financing-₹3.12-₹1.02-₹1.08-₹0.57
Total Cash Flow-₹28.91₹9.18₹28.99-₹14.77
Cash (Start of the year)₹57.52₹48.96₹21.21₹43.26
Cash (End of the year)₹25.12₹57.52₹48.96₹21.21

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹264.00₹267.30₹278.25₹301.78
Current Assets₹451.72₹359.52₹322.84₹278.04
Total Assets₹715.72₹626.82₹601.08₹579.82
Current Liabilities₹136.29₹79.42₹82.57₹92.74
Net Current Asset₹315.43₹280.11₹240.26₹185.30
Non-Current Liabilities₹18.48₹59.86₹58.17₹46.63
Equity Capital₹560.95₹487.55₹460.34₹440.45
Total Equity & Liabilities₹715.72₹626.82₹601.08₹579.82

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹639.46₹575.21₹537.66₹576.71
Other Income₹20.78₹11.32₹10.17₹8.43
Total Revenue₹660.24₹586.53₹547.84₹585.14
Total Expenses₹591.08₹539.88₹507.51₹540.47
Profit Before Tax₹79.08₹46.65₹40.33₹44.67
Tax₹26.51₹16.15₹11.36-₹4.32
Profit After Tax₹52.56₹30.50₹28.96₹48.99
EPS - Basic₹39.32₹22.82₹21.67₹37.12
EPS - Diluted₹39.32₹22.82₹21.67₹37.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹130.67₹69.16₹46.65₹40.33
Income before WC changes₹148.03₹85.28₹66.01₹62.58
Change in Assets-₹15.75-₹7.85-₹16.70-₹24.98
Change in Liabilities₹53.08₹20.59₹1.56-₹9.55
Change in WC₹37.33₹12.74-₹15.15-₹34.53
Cash flow from Operations₹151.09₹83.10₹35.38₹28.05
Cash flow from Investing-₹181.57-₹76.20-₹6.94-₹50.81
Cash flow from Financing-₹1.39₹0.00₹0.00₹0.00
Total Cash Flow-₹31.86₹6.90₹28.44-₹22.76
Cash (Start of the year)₹55.41₹48.51₹20.07₹42.83
Cash (End of the year)₹23.54₹55.41₹48.51₹20.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹277.46₹280.26₹290.70₹314.25
Current Assets₹435.75₹361.00₹318.19₹264.41
Total Assets₹713.21₹641.26₹608.89₹578.66
Current Liabilities₹105.23₹72.81₹72.67₹82.61
Net Current Asset₹330.51₹288.18₹245.53₹181.80
Non-Current Liabilities₹18.48₹59.86₹58.17₹46.63
Equity Capital₹589.49₹508.59₹478.05₹449.41
Total Equity & Liabilities₹713.21₹641.26₹608.89₹578.66
* All values are in INR Crore
Qty
Bid
1000
1574.3
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1000
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
41.99
Neutral
ATR (14)
95.69
Neutral
STOCH(9,6)
7.65
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
24.46
Bearish
UO(9)
46.5
Neutral
ROC(12)
-2.42
Bearish
WillR(14)
-92.35
Bullish
Period
Simple value
Exponential vaue
5D
1653.28
1639.89
10D
1709.45
1665.19
20D
1653.89
1666.72
50D
1652.63
1648.17
100D
1645.86
1552.83
Volume trend — traded volume by day
14 Oct0L
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
VENUS REMEDIES
Pharmaceuticals
Add Stock
Add Another

VENUS REMEDIES Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.